-
公开(公告)号:JPH10243794A
公开(公告)日:1998-09-14
申请号:JP5009797
申请日:1997-03-05
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI
IPC: C12P17/04 , C07D307/88 , C12R1/40 , C12R1/685
Abstract: PROBLEM TO BE SOLVED: To easily obtain the subject compound useful e.g. as a component of bathing agent and cosmetic in high yield by treating a 2-alkylbenzoic acid with a microorganism having asymmetric hydroxylation potency and carrying out intramolecular esterification of the resultant product. SOLUTION: A 2-alkylbenzoic acid expressed by the formula I (R is a linear or branched-chain alkyl or alkenyl; R is H, an alkyl, an alkenyl or an aryl) is treated with a microorganism having asymmetric hydroxylation potency such a Pseudomonas putida ATCC12633, Aspergillus niger IFO 4091 or Aspergillus niger IFO 6661 and the resultant product is subjected to intermolecular esterification to easily obtain the objective optically active 3- substituted phthalide expressed by the formula II ((*) shows that the steric configuration of the position is S or R) and useful as a component of a bathing agent or a cosmetic in high yield.
-
公开(公告)号:JPH0733758A
公开(公告)日:1995-02-03
申请号:JP17709093
申请日:1993-07-16
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , NISHIZAWA YOSHINORI
IPC: C07D309/30 , C07F7/18
Abstract: PURPOSE:To obtain a compound useful as a synthetic intermediate for physiologically active substances such as pheromones. CONSTITUTION:This (S)-2-(t-butyldimethylsilyloxy)-1-nitropropane is expressed by the formula. The compound can be obtained at a low cost on a large scale by reacting (S)-1-nitro-2-propanol with t-butyldimethylsilyl chloride in a solvent such as DMF. Furthermore, this compound can be used as a raw material and subjected to the Michael addition reaction with methyl vinyl ketone in the presence of a base and subsequently the denitration hydrogenating reaction in tributylstannane/azobisisobutyronitrile system to afford optically active 6-(t- butyldimethylsilyloxy)-2-heptanone.
-
公开(公告)号:JPH06227958A
公开(公告)日:1994-08-16
申请号:JP1286193
申请日:1993-01-28
Applicant: KAO CORP
Inventor: HORI TAKASHI , KITAYAMA TAKASHI , NISHIZAWA YOSHINORI , KIMURA MITSUTOSHI , YADA YUKIHIRO , IMOKAWA GENJI
IPC: A61K8/30 , A61K8/00 , A61K8/41 , A61K8/42 , A61K31/135 , A61K31/16 , A61K31/165 , A61P17/00 , A61Q19/00 , A61Q19/02 , A61K7/48 , A61K7/00
Abstract: PURPOSE:To obtain the subject external agent for skin excellent in the treatment of pigmentation caused by the spots, freckles, sun-burn, etc., stability and safety by compounding a phenylalaninol derivative or a tyrosinol derivative as an effective component. CONSTITUTION:A phenylalaninol derivative or a tyrosinol derivative of formula I (R is H or OH; R and R are H or alkyl; R is H, alkanoyl or benzoyl), e.g. L-tyrosinol is, as an effective component, compounded in an amount of 0.01-50wt.%, preferably 0.1-20wt.%, based on the total composition. The composition is formulated as a cosmetic in a form of lotion, milky lotion, cream, ointment, stick, solution, pack, jell, etc. A compound of formula I is obtained by suspending a phenylalanin derivative or a tyrosin derivative of formula II in alcohol, adding thionyl chloride dropwise under heating and stirring to lead to the ester, adding benzoyl chloride or an alkanoyl chloride dropwise to lead to a compound of formula III and finally subjecting this compound to reduction.
-
公开(公告)号:JPH05148173A
公开(公告)日:1993-06-15
申请号:JP30491091
申请日:1991-11-20
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , ANDO MASATOMO , NISHIZAWA YOSHINORI , IMOKAWA GENJI , JOKURA HIROKO , KOBAYASHI TAKESHI
IPC: A61K8/30 , A61K8/00 , A61K8/33 , A61K8/34 , A61K8/35 , A61K8/37 , A61K8/40 , A61K31/045 , A61K31/05 , A61K31/085 , A61K31/095 , A61K31/12 , A61K31/215 , A61K31/275 , A61P17/00 , A61P43/00 , A61Q17/00 , C07C39/11 , C07C49/245 , C07C49/255 , C07C69/732 , C07C69/734 , C07C69/738 , C07C205/17 , C07C205/45 , C07C255/35 , C07C255/36 , C07C255/37 , C07C255/40
Abstract: PURPOSE:To obtain the subject medicine containing a specific benzylketone derivative as an active ingredient, capable of strongly suppressing activity of tyrosinase which is an enzyme necessary for melamine synthesis and of exhibiting an excellently preventing effect on melanine pigmentation with nearly no by-effect. CONSTITUTION:The objective medicine contains a benzylketone derivative of the formula (R is H, OH, etc.; R is H, cyano, etc.; R is alkyl, benzyl, etc.; X is O or OH; broken line exhibits possibility of double bond) as an active ingredient, preferably in an amount of 0.1-20wt.%. The compound of the formula is obtained by reacting ethyl p-methoxyphenylacetate with acetyl fluoride in the presence of a base to afford an intermediate and then subjecting the intermediate to acid treatment. Furthermore, the compound of the formula wherein R is OH or nitro and R is 1-10C alkyl, nitrobenzyl, etc., is a new substance.
-
公开(公告)号:JPH05139946A
公开(公告)日:1993-06-08
申请号:JP30342991
申请日:1991-11-19
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , ANDO MASATOMO , NISHIZAWA YOSHINORI , IMOKAWA GENJI , JOKURA HIROKO , KOBAYASHI TAKESHI
Abstract: PURPOSE:To obtain a melanin inhibitor strongly suppressing enzyme activity related to melanin synthesis, having excellently improving effects on melanization, comprising a benzyl phenyl, ketone derivative as an active ingredient. CONSTITUTION:A melanin inhibitor comprising 0.01-50wt.%, preferably 0.1-20wt.% compound of the formula (R to R are H, OH or lower alkoxy; R is H, OH or cyano) such as 3,4-dihydroxyphenyl-p-hydroxybenzyl ketone as an active ingredient. The inhibitor can be prepared into a form such as lotion, milky lotion, pack or gel. The inhibitor is locally applied to an affected part such as stain of skin, freckle, chromatosis after suntan. The amount of the inhibitor used is 1-20mg based on 1cm skin face in the case of cream or ointment and 1-10mg in the case of liquid.
-
公开(公告)号:JPH07206843A
公开(公告)日:1995-08-08
申请号:JP325494
申请日:1994-01-17
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , NISHIZAWA YOSHINORI , FUKUDA YUKIO , HORI KIMIHIKO
IPC: C07D307/88 , A61K8/00 , A61K8/30 , A61K8/49 , A61K31/34 , A61K31/343 , A61P9/08 , A61P17/00 , A61Q5/00 , A61Q7/00 , A61Q19/00 , A61Q19/10 , A61K7/00 , A61K7/06 , A61K7/48 , A61K7/50
Abstract: PURPOSE:To provide a vasodilator containing a dialkylphthalide derivative represented by a specific formula as an active ingredient, not generating a simple smell, useful as an agent for preventing and treating various diseases caused by the blood circulation disorder of skin or scalp, and thereby suitable as a skin external agent, a bathing agent, etc. CONSTITUTION:This vasodilator contains a dialkylphthalide derivative of formula I (R1, R2 are alkyl; R3 is H, OH, lower alkoxy), e.g. 3,3-dimethylphthalide, as an active ingredient. The derivative is preferably obtained e.g. by reacting phthalic anhydride of formula II with a Grignard reagent, etc.
-
公开(公告)号:JPH07188208A
公开(公告)日:1995-07-25
申请号:JP33234293
申请日:1993-12-27
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , ICHINOSE SUSUMU , HORI TAKASHI , NISHIZAWA YOSHINORI , KIMURA MITSUTOSHI , YADA YUKIHIRO , IMOKAWA GENJI
IPC: C07D311/22 , A61K8/00 , A61K8/49 , A61K31/35 , A61K31/352 , A61P17/00 , A61Q17/04 , A61Q19/00 , A61K7/00 , A61K7/42 , A61K7/48
Abstract: PURPOSE:To obtain a skin external preparation containing a partially new chromone derivative as an active ingredient, capable of suppressing melanogenesis in a pigment freckle artificially formed, exhibiting excellent melanization-preventing effect without almost exhibiting adverse effects and, simultaneously, being stable to light. CONSTITUTION:This skin external preparation, especially a melanin suppressor contains a partially new chromone derivative expressed by formula 1-(1) (R is a 1-15C straight-chain or branched chain alkyl; R is H, OH or a lower alkoxy) as an active ingredient. The compound of formula I-(1) includes a chromone derivative of formula II R ' is a 3-15C branched chain alkyl), e.g. 2-butylchromone. The chromone derivative expressed by formula I-(1) is readily obtained by cyclizing a compound expressed by formula T-(2) with a compound expressed by formula I-(3) in the presence of a base and heating and dehydrating the resultant compound in the presence of an acid such as hydrochloric acid.
-
公开(公告)号:JPH0632727A
公开(公告)日:1994-02-08
申请号:JP18819892
申请日:1992-07-15
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , ANDO MASATOMO , NISHIZAWA YOSHINORI , IMOKAWA GENJI , KIMURA MITSUTOSHI
IPC: A61K8/30 , A61K8/00 , A61K8/44 , A61K31/195 , A61K31/198 , A61K31/215 , A61P17/00 , A61P43/00 , A61Q19/00 , A61Q19/02 , C07C229/36 , A61K7/48 , A61K7/00
Abstract: PURPOSE:To obtain an external preparation for skin having inhibitory action on melanism, excellent preventing effects on stain, freckle and pigmentation on skin after sunburn and high stability and safety. CONSTITUTION:This external preparation for skin comprises 0.01-50wt.%, especially 0.1-20wt.% based on the whole amount of the ternal preparation for skin of a BETA-branched phenylalanine derivative of the formula (R is H or OH; R is lower alkyl; R is H or lower alkyl) or its salt, preferably BETA- methylphenylalanine. The external preparation for skin is prepared in a lotion state, milky lotion state, creamy state, ointment state, stick state, solution state with an organic solvent, pack state or gelatinous state.
-
公开(公告)号:JPH05345713A
公开(公告)日:1993-12-27
申请号:JP15523992
申请日:1992-06-15
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , ANDO MASATOMO , NISHIZAWA YOSHINORI , IMOKAWA GENJI , KIMURA MITSUTOSHI
IPC: A61K8/49 , A61K8/00 , A61K31/415 , A61K31/4166 , A61P17/00 , A61P43/00 , A61Q19/00 , A61Q19/02 , C07D233/78 , A61K7/48 , A61K7/00
Abstract: PURPOSE:To provide hydantoin derivatives (including new compounds) having pigmentation preventing and improving effects and excellent safety and stability and easily miscible to a cosmetic base, etc. CONSTITUTION:The objective melanogenesis suppressing agent is composed of a compound of formula I [R is H, lower alkyl or aralkyl; R is H, alkyl (which may contain epoxy group or ketone group), lower alkoxycarbonyl or lower alkoxycarbonylalkyl; dotted line represents the presence or absence of double bond], e.g. 5-(p-methoxybenzylidene)hydantoin. Compounds of formula wherein R is not aralkyl and R is not H are new compounds. The compound strongly inhibits the activity of tyrosinase which is an essential enzyme for melanin synthesis and suppresses the melanogenesis in the artificially formed pigment freckle. The amount of the compound to be compounded to the total external agent is 0.01-50wt.%, especially 0.1-20wt.%.
-
公开(公告)号:JPH05213857A
公开(公告)日:1993-08-24
申请号:JP1653592
申请日:1992-01-31
Applicant: KAO CORP
Inventor: KITAYAMA TAKASHI , ANDO MASATOMO , NISHIZAWA YOSHINORI , IMOKAWA GENJI , JOKURA HIROKO , KOBAYASHI TAKESHI
IPC: A61K8/30 , A61K8/00 , A61K8/46 , A61Q17/04 , A61Q19/02 , C07C323/18 , C07C323/62
Abstract: PURPOSE:To obtain a melanin inhibitor, containing an aryl sulfide derivative as an active ingredient and excellent in improving effects on pigmentation and blending properties in cosmetic bases. CONSTITUTION:The objective melanin inhibitor is obtained by including a compound of the formula [R to R are H, OH or acetoxyl; X is lower alkyl, lower acyl, hydroxyphenyl, hydroxyphenylthio or CH2COCH2COR substituted with OH, carboxyl or lower alkoxy)], e.g. 2-(p-hydroxyphenylthio)ethanol as an active ingredient in an amount of 0.01-50wt.% in the total composition. The inhibitor can locally be applied to dermal stains, ephelides or sunburned pigmented parts of the skin to treat and improve the parts and return the skin to its normal color. This inhibitor can be prepared as a cosmetic in the form of a lotion, a milky lotion, a cream, an ointment, a stick, a pack, a get, etc. In the case of the cosmetic in the form of the cream or ointment, it is applied in an amount of 1-20mg per cm skin surface. In the case of the cosmetic in the form of the liquid formulation, it is similarly applied in an amount of 1-10mg per cm skin surface.
-
-
-
-
-
-
-
-
-